Items Tagged ‘Hodgkin’s Lymphoma’

March 22, 2018

FDA Approves Adcetris® in Combination with Chemotherapy for Previously Untreated Stage III or IV Classical Hodgkin Lymphoma

By

CancerConnect News: The U.S. Food and Drug Administration (FDA) has approved Adcetris (brentuximab vedotin) in combination with chemotherapy in adult patients with previously untreated Stage III or IV classical Hodgkin lymphoma. The approval is based on the successful outcome of the ECHELON-1 clinical trial that compared Adcetris plus AVD (Adriamycin, vinblastine and dacarbazine) to ABVD […]

View full entry

Tags: adcetris, brentuximab, classical, hodgkin lymphoma, Hodgkin's Lymphoma, News, Precision Cancer Medicine, vedotin


March 1, 2018

Addition of the Precision Cancer Medicine Adcetris Reduces the Risk of Treatment Failure in Advanced Hodgkin Lymphoma

By

CancerConnect News: Patients with advanced Hodgkin lymphoma (HL) who were treated with a multi-drug regimen that included the precision cancer medicine Adcetris (brentuximab vedotin) had a 23-percent reduction in the risk of disease progression, death, or the need for additional therapy, compared with patients who received the standard treatment for advanced HL.1 Hodgkin’s lymphoma is […]

View full entry

Tags: ABVD, adcetris, brentuximab, hodgkin lymphoma, Hodgkin's Lymphoma, News, Precision Cancer Medicine, vedotin


February 6, 2009

Lymphoma Patients: Understanding Peripheral Neuropathy

By

If you’ve received chemotherapy as part of your lymphoma treatment, one of the side effects you may experience is numbness and tingling in you extremities, also known as peripheral neuropathy. The following guidelines explain how to recognize and manage this condition. What Is Peripheral Neuropathy? Numbness and tingling of your extremities (hands and feet) is […]

View full entry

Tags: Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma


February 6, 2009

It's Not Just a Little Fever: Preventing Infection during Therapy for Lymphoma

By

Many cancer patients are at an increased risk of infection because of their low levels of infection-fighting white blood cells, a condition called neutropenia. The most common reason that cancer patients experience neutropenia is as a side effect of chemotherapy. Chemotherapy involves the use of drugs to destroy cancer cells. Chemotherapy works by destroying cells […]

View full entry

Tags: Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma


February 6, 2009

Successful Treatment for Lymphoma Means Staying on Schedule

By

In order to receive the best possible benefit from your lymphoma therapy, it is important to follow your treatment as your doctor has prescribed. Even if you’re not able to visit your regular treatment facility, chances are good that you can still maintain your schedule; many other doctors, nurses, and healthcare providers are able to […]

View full entry

Tags: Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma


February 6, 2009

Understanding Stem Cell Transplants

By

High-dose chemotherapy and bone marrow or blood stem cell transplantation (SCT) remains the best treatment available for selected patients with certain types of leukemia. The SCT process was developed more than 36 years ago and was considered such a major development of biomedical science that the individuals responsible were awarded the Nobel Prize for Medicine […]

View full entry

Tags: Hodgkin's Lymphoma, Multiple Myeloma


February 5, 2009

Hodgkin's Survivors: Increased Fatigue, Cardiac, and Thyroid Complications

By

According to an article published in the Annals of Oncology, survivors of Hodgkin’s lymphoma have a significantly increased rate of cardiac and thyroid complications than their siblings. In addition, survivors tend to have more fatigue than their siblings; however, this may in part be associated with cardiac issues. Researchers from the Brigham and Women’s Hospital […]

View full entry

Tags: Advanced Stage Hodgkin's Lymphoma, Early Stage Hodgkin's Lymphoma, Hodgkin's Lymphoma, Progressive Relapsed Hodgkin's Lymphoma


February 5, 2009

Patients with Hodgkin’s Lymphoma at Risk for Heart Attack Later in Life

By

Patients treated for Hodgkin’s lymphoma are at an increased risk of death from a heart attack for 25 years following therapy. In order to reduce the risk of death from cardiac complications, individuals diagnosed with Hodgkin’s lymphoma may wish to discuss monitoring procedures for the early detection and treatment of heart conditions. Hodgkin’s lymphoma is a […]

View full entry

Tags: Hodgkin's Lymphoma


February 5, 2009

What You Should Know About Bone Marrow Biopsy for the Staging of Lymphoma

By

Cancers that begin in cells of the lymph system are referred to as malignant lymphomas. The lymph system includes the spleen, thymus, tonsils, bone marrow, lymph nodes and circulating white blood cells called lymphocytes. Lymphocytes and the lymph system are part of the immune system that protects the body from disease and infection. Cancers of […]

View full entry

Tags: Hodgkin's Lymphoma